Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2015

View Archived Issues

Acquisitions: recent news

Auspherix raises financing to develop antibacterials

Pluristem receives support from Israeli government to develop PLX-PAD in Japan

Collaborations: recent news

Phase III study finds biosimilar BCD-021 equivalent to Avastin in NSCLC

Phase III trial of dendritic cell vaccine for RCC recommended to continue

Enrollment complete in Apios's phase I/II trial of bryostatin-1 in HIV infection

Casi seeks Chinese approval to begin phase II trial of ENMD-2076 in fibrolamellar carcinoma

EMA committee adopts positive opinion on pediatric investigation plan for Viaskin Peanut

Arno Therapeutics enters into CRADA with the U.S. Army to study the antiviral activity of AR-12

Catabasis reports preliminary phase I data on CAT-2054 for hypercholesterolemia

RESONATE-2 trial of ibrutinib in CLL/SLL meets key endpoints

ATF6 may have a relevant role in the development of achromatopsia

Symbiotix Biotherapies awarded NIAID grant to develop microbiome-derived therapeutics

Ardelyx regains rights to tenapanor, raises investment and reveals hyperkalemia candidates

FDA clears IND for clinical trials of Q-Cells for ALS

Janssen initiates rolling BLA submission for daratumumab in multiple myeloma

Nihon Medi-Physics and University of Kyoto patent diagnostics for aldosteronism

Verona Pharma advances clinical study of new nebulized formulation of RPL-554 for COPD

Wroclaw Research Centre EIT+ presents new compounds to treat infection

Corcept Therapeutics discloses GR modulators

Allergan presents FPR2 modulators

Rhythm initiates phase II trials of setmelanotide in Prader-Willi syndrome and POM-null obesity

Scientists disclose phase I results for G-305

FDA gives clearance to Roche's cobas HSV 1 and 2 test

Encouraging phase II data reported for selinexor in gynecological malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...